Sea Mild Biotechnology Co., Ltd. (TPEX:7516)
Taiwan · Delayed Price · Currency is TWD 8.65
-0.11 (-1.26%)
Aug 14, 2026, 1:13 PM CST
Sea Mild Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 8.84 | 31.99 | 6.19 | -21.38 | -52.05 |
Depreciation & Amortization | 23.4 | 19.06 | 14.49 | 15.17 | 20.84 |
Loss (Gain) From Sale of Assets | -0.23 | - | -0.28 | 0.11 | -3.3 |
Asset Writedown & Restructuring Costs | - | -7.97 | - | 9 | 10 |
Provision & Write-off of Bad Debts | - | - | - | -0.05 | -1.54 |
Other Operating Activities | -0.53 | 0.92 | -0.87 | -0.11 | 10.06 |
Change in Accounts Receivable | -15.07 | -11.02 | 1.46 | -9.32 | 3.15 |
Change in Inventory | -10.14 | -29.21 | -12.04 | 4.37 | 7.45 |
Change in Accounts Payable | 7.58 | 13.15 | -1.97 | 10.57 | -3.86 |
Change in Unearned Revenue | -0.03 | 0.28 | -0.32 | -0.73 | 1.35 |
Change in Other Net Operating Assets | -6.19 | 17.05 | 2.18 | 4.06 | -4.44 |
Operating Cash Flow | 7.63 | 34.25 | 8.84 | 11.71 | -12.35 |
Operating Cash Flow Growth | -77.72% | 287.54% | -24.51% | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -15.02 | -11.28 | -1.25 | - | -2.85 |
Sale of Property, Plant & Equipment | 0.23 | - | - | 0.35 | 0.06 |
Sale (Purchase) of Intangibles | - | - | - | -0.29 | -0.54 |
Sale (Purchase) of Real Estate | - | - | - | - | 13.57 |
Other Investing Activities | 4.22 | 1.64 | -12.41 | -2.37 | -0.35 |
Investing Cash Flow | -10.58 | -9.64 | -13.65 | -2.31 | 9.88 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 20 | 5 | 21.95 | 3.05 | - |
Long-Term Debt Issued | 20 | 20 | - | - | - |
Total Debt Issued | 40 | 25 | 21.95 | 3.05 | - |
Long-Term Debt Repaid | -30.11 | -13.3 | -11.1 | -10.86 | -10.66 |
Total Debt Repaid | -30.11 | -13.3 | -11.1 | -10.86 | -10.66 |
Net Debt Issued (Repaid) | 9.89 | 11.7 | 10.85 | -7.81 | -10.66 |
Other Financing Activities | - | 0.01 | - | - | - |
Financing Cash Flow | 9.89 | 11.71 | 10.85 | -7.81 | -10.66 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.7 | - | 0.02 | 0.05 | 0.01 |
Net Cash Flow | 6.26 | 36.32 | 6.05 | 1.63 | -13.12 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.39 | 22.97 | 7.59 | 11.71 | -15.2 |
Free Cash Flow Growth | - | 202.56% | -35.16% | - | - |
Free Cash Flow Margin | -2.16% | 7.20% | 2.95% | 5.78% | -9.28% |
Free Cash Flow Per Share | -0.38 | 1.19 | 0.39 | 0.61 | -0.79 |
Levered Free Cash Flow | -14.43 | 12.22 | 2.12 | 8.9 | 8.45 |
Unlevered Free Cash Flow | -12.89 | 13.01 | 2.72 | 9.33 | 8.97 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 2.46 | 1.26 | 0.97 | 0.68 | 0.83 |
Cash Income Tax Paid | 0.03 | 0.03 | - | - | - |
Change in Working Capital | -23.84 | -9.74 | -10.69 | 8.96 | 3.65 |